Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genpact (G) Asset Writedowns and Impairment: 2009-2025

Historic Asset Writedowns and Impairment for Genpact (G) over the last 14 years, with Sep 2025 value amounting to $7.0 million.

  • Genpact's Asset Writedowns and Impairment was N/A to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.8 million, marking a year-over-year change of. This contributed to the annual value of $13.8 million for FY2024, which is 246.97% up from last year.
  • Latest data reveals that Genpact reported Asset Writedowns and Impairment of $7.0 million as of Q3 2025, which was down 36.54% from $11.1 million recorded in Q2 2025.
  • Genpact's Asset Writedowns and Impairment's 5-year high stood at $31.5 million during Q4 2022, with a 5-year trough of -$1.4 million in Q3 2023.
  • For the 3-year period, Genpact's Asset Writedowns and Impairment averaged around $4.3 million, with its median value being $3.3 million (2023).
  • Data for Genpact's Asset Writedowns and Impairment shows a peak YoY increase of 3,508.65% (in 2022) and a maximum YoY decrease of 163.69% (in 2022) over the last 5 years.
  • Genpact's Asset Writedowns and Impairment (Quarterly) stood at -$925,000 in 2021, then surged by 3,508.65% to $31.5 million in 2022, then slumped by 103.50% to -$1.1 million in 2023, then spiked by 228.04% to $1.4 million in 2024, then surged by 535.78% to $7.0 million in 2025.
  • Its Asset Writedowns and Impairment stands at $7.0 million for Q3 2025, versus $11.1 million for Q2 2025 and $7.3 million for Q1 2025.